During the past decade, Ospedale Civile Cosenza conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Civile Cosenza" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 4 trials, followed by "Associazione Qol-one" with 3 trials sponsored, "Anthos Therapeutics, Inc." with 2 trials sponsored, "European Institute of Oncology" with 2 trials sponsored and "Gruppo di Ricerca GISSI" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Civile Cosenza" #1 collaborator was "Itreas" with 2 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile Cosenza" are "Lung Cancer" (3 trials), "Deep Venous Thrombosis" (2 trials), "Myelodysplastic Syndromes" (2 trials), "Pulmonary Embolism" (2 trials) and "Venous Thromboembolism" (2 trials). Many other conditions were trialed in "Ospedale Civile Cosenza" in a lesser frequency.

Most popular intervention types in "Ospedale Civile Cosenza" are "Drug" (17 trials), "Procedure" (4 trials), "Biological" (3 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Abelacimab" (2 trials), "Eltrombopag/Revolade" (2 trials), "Prednisone" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile Cosenza" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Civile Cosenza". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ospedale Civile Cosenza, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile Cosenza, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".